Top View
- Integrative Omics Analysis Identi Es Subtypes with Therapeutic
- (+)-Clausenamide Protects Against Drug-Induced Liver Injury By
- The KEAP1–NRF2 System As a Molecular Target of Cancer Treatment
- CRISPR/Cas9 Genome-Wide Screening Identifies KEAP1 As a Sorafenib, Lenvatinib, and Regorafenib Sensitivity Gene in Hepatocellular Carcinoma
- NRF2-Driven KEAP1 Transcription in Human Lung Cancer
- O-Glcnacylation and Its Role in the Immune System Yi-Hsuan Chang1†, Chia-Lin Weng1,2† and Kuo-I Lin1,2*
- The Effects of Macrophage Migration Inhibitory Factor on Antioxidant Responses During Cigarette Smoke Exposure
- Proteostasis in Huntington's Disease
- NRF2 Intensifies Host Defense Systems to Prevent Lung Carcinogenesis, but After Tumor Initiation Accelerates Malignant Cell Growth
- Roles of CNC Transcription Factors NRF1 and NRF2 in Cancer
- KEAP1 Gene Mutations and NRF2 Activation Are Common in Pulmonary Papillary Adenocarcinoma
- Investigation of Molecular Details of Keap1-Nrf2 Inhibitors Using Molecular Dynamics and Umbrella Sampling Techniques
- A New Connection Between Intracellular Glycosylation and Redox Stress Signaling in Cancer Cells
- Rabbit Mab A
- Proteomic Analysis of Ubiquitin Ligase KEAP1 Reveals Associated Proteins That Inhibit NRF2 Ubiquitination
- NRF2 Activation in Cancer: from DNA to Protein Erica W
- NRF2-Driven KEAP1 Transcription in Human Lung Cancer Yijun Tian1, Qian Liu1, Shengnan Yu2, Qian Chu2, Yuan Chen2, Kongming Wu2,3, and Liang Wang1,4
- Human Kelch-Like ECH- Associated Protein 1 (KEAP1) a Target Enabling Package (TEP)
- Genome-Wide CRISPR Screen Reveals Autophagy Disruption As the Convergence Mechanism That Regulates the NRF2 Transcription Factor
- Keap1 Polyclonal Antibody Catalog # AP73401
- Glycosylation of Gigaxonin Regulates Intermediate Filaments: Novel Molecular
- A Novel Kelch-Like-1 Is Involved in Antioxidant Response by Regulating Antioxidant Enzyme System in Penaeus Vannamei
- Cancer Related Mutations in NRF2 Impair Its Recognition by Keap1-Cul3 E3 Ligase and Promote Malignancy
- Pharmacogenomics of Chemically Distinct Classes of Keap1-Nrf2 Activators Identify Common and Unique Gene, Protein, and Pathway Responses in Vivo
- Oncogenic Activation of Nrf2 by Specific Knockout of Nrf1α That Acts
- ATDC Binds to KEAP1 to Drive NRF2- Mediated Tumorigenesis and Chemoresistance in Pancreatic Cancer
- Pharmacogenomics of Chemically Distinct Classes of Keap1-Nrf2 Activators Identify Common and Unique Gene, Protein, and Pathway R
- KEAP1 Is Required for Artesunate Anticancer Activity in Non-Small-Cell Lung Cancer
- Investigation of a Role for the Endosomal Deubiquitylase USP8 in Cancer Cell Survival Pathways
- Loss of Keap1 Function Activates Nrf2 and Provides Advantages for Lung